wire - news in brief

« BACK

Business/Economics



Results 1 - 50 of 428.
1 2 3 4 5 9 Next »


Environment / Sustainable Development - Business / Economics - 20.06.2018
Federal Council adopts Switzerland's country report on implementation of the 2030 Agenda
Bern, 20.06.2018 - At its meeting on 20 June 2018, the Federal Council adopted Switzerland's country report on the implementation of the 2030 Agenda for Sustainable Development.

Medicine / Pharmacology - Business / Economics - 01.06.2018
Sandoz receives positive CHMP opinion for proposed biosimilar adalimumab
Sandoz is seeking approval of proposed biosimilar adalimumab for use in all reference medicine indications including those in rheumatology, gastroenterology and dermatology Positive CHMP opinion base

Medicine / Pharmacology - Business / Economics - 18.05.2018
Novartis and Amgen announce FDA approval of Aimovig(TM) (erenumab), a novel treatment developed specifically for migraine prevention
Migraine is a severe neurologic disease that profoundly impacts millions of patients in the United States   Aimovig is the first and only FDA-approved treatment to block the calcitonin gene-related p

Business / Economics - Medicine / Pharmacology - 16.05.2018

Medicine / Pharmacology - Business / Economics - 15.05.2018

Medicine / Pharmacology - Business / Economics - 15.05.2018

Medicine / Pharmacology - Business / Economics - 08.05.2018

Medicine / Pharmacology - Business / Economics - 07.05.2018

Environment / Sustainable Development - Business / Economics - 24.04.2018
StructuralNavigation_Title
StructuralNavigation_Title
Many people live at home up to a ripe old age without needing much outside help.

Medicine / Pharmacology - Business / Economics - 17.04.2018
Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials
Company to invest more than USD 100 million to advance research and development of new antimalarials over the next five years   Commitment includes expanding access to pediatric antimalarials and imp

Business / Economics - Medicine / Pharmacology - 17.04.2018

Business / Economics - 12.04.2018

Medicine / Pharmacology - Business / Economics - 06.04.2018

Environment / Sustainable Development - Business / Economics - 16.03.2018

Medicine / Pharmacology - Business / Economics - 12.03.2018

Administration / Government - Business / Economics - 09.03.2018

Business / Economics - Medicine / Pharmacology - 06.03.2018

Business / Economics - Careers / Employment - 02.03.2018
Jobs, wages, higher after-tax pay keeps consumer confidence high
ANN ARBOR-Consumer sentiment has remained at very favorable levels for more than a year. In the February survey, it was just below the October 2017 peak of 100.7, the highest level since 2004, according to the University of Michigan Surveys of Consumers.

Business / Economics - 02.03.2018
U-M expert discusses Trump, tariffs, trade
U-M expert discusses Trump, tariffs, trade
FACULTY Q&A President Trump's announcement to impose stiff tariffs on aluminum and steel imports is causing alarm among trade partners who fear the tariffs could lead to a trade war.

Innovation / Technology - Business / Economics - 27.02.2018

Business / Economics - Academic Rankings - 23.02.2018

Business / Economics - Medicine / Pharmacology - 22.02.2018
Family Larsson-Rosenquist Foundation to Finance New Center for Research into Long-Term Effects of Breastfeeding
What are the reasons a mother does or does not breastfeed? What effect does the decision have on the child, the mother, and society? Although there is a lot of scientific evidence for the health benef

Physics / Materials Science - Business / Economics - 22.02.2018
Empa presents
Empa presents "gas station of the
What could a "gas station of the future" look like? What services does it offer? Which fuels can be refueled there and where do they come from? Possible answers to these questions can be found at the stand of the of Swiss Oil Industry Association (Erdöl-Vereinigung) at the Geneva Motor Show.

Business / Economics - Life Sciences - 15.02.2018

Medicine / Pharmacology - Business / Economics - 08.02.2018

Medicine / Pharmacology - Business / Economics - 26.01.2018

Business / Economics - Medicine / Pharmacology - 24.01.2018
Novartis delivered good operational performance and landmark innovation in 2017, entering our next growth phase
Full year sales grew 2% (cc, +1% USD) as strong performance of our growth drivers, including Cosentyx and Entresto , more than offset Gleevec/Glivec generic erosion: Cosentyx grew to USD 2.1 bi

Medicine / Pharmacology - Business / Economics - 11.01.2018

Innovation / Technology - Business / Economics - 19.12.2017
Teams up with partner organizations to build "digital trust"
EPFL President Martin Vetterli has today unveiled plans to create the EPFL Center for Digital Trust.

Medicine / Pharmacology - Business / Economics - 15.12.2017

Medicine / Pharmacology - Business / Economics - 14.12.2017

Medicine / Pharmacology - Business / Economics - 07.12.2017

Medicine / Pharmacology - Business / Economics - 30.10.2017
Novartis announces the planned acquisition of Advanced Accelerator Applications to strengthen oncology portfolio
Novartis to acquire Advanced Accelerator Applications pending outcome of tender offer and works council consultation   Acquisition would add Lutathera , a first-in-class RadioLigand Therapy (RLT) app
1 2 3 4 5 9 Next »